Literature DB >> 17184969

The effectiveness of Teratology Information Services (TIS).

Rebecca L Hancock1, Gideon Koren, Adrienne Einarson, Wendy J Ungar.   

Abstract

BACKGROUND: Women and their health care providers have few reliable sources of information regarding the safety of exposures in pregnancy and lactation. Evidence-based information on these topics is provided by Teratology Information Services (TIS). Access to TIS, however, is limited in many regions, and many services have difficulty maintaining ongoing funding. The objective of this review is to highlight published reports of the effectiveness of TIS in improving maternal and neonatal health.
METHODS: A search of the Pub Med and Econ Lit databases was performed with no date restriction, using the search terms teratology, information, counseling, pregnancy, effectiveness, birth defects.
RESULTS: Information disseminated from TIS has been shown to prevent congenital malformations, unnecessary pregnancy terminations, and occupational risks. TIS support optimal nutritional supplementation in pregnancy and optimal drug therapy in pregnancy and breast-feeding. In addition, they correct misperceptions of risk and facilitate knowledge transfer and translation. TIS have the potential to provide health care cost savings.
CONCLUSIONS: TIS are vital services in supporting optimal maternal and neonatal health. A formal economic evaluation of TIS is required in order to inform resource allocation decision-making and continued funding of these services.

Entities:  

Mesh:

Year:  2006        PMID: 17184969     DOI: 10.1016/j.reprotox.2006.11.005

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  13 in total

1.  Drug use in pregnancy--physicians' evaluation of quality and clinical impact of drug information centres.

Authors:  Sofia Kristina Frost Widnes; Jan Schjøtt
Journal:  Eur J Clin Pharmacol       Date:  2008-12-04       Impact factor: 2.953

2.  Advice on drug safety in pregnancy: are there differences between commonly used sources of information?

Authors:  Sofia K Frost Widnes; Jan Schjøtt
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Research in the field of drug therapy safety management.

Authors:  Horst Möller; Amin-Farid Aly
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

4.  Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers.

Authors:  Ulrika Nörby; Karin Källén; Birgit Eiermann; Seher Korkmaz; Birger Winbladh; Lars L Gustafsson
Journal:  Eur J Clin Pharmacol       Date:  2012-09-26       Impact factor: 2.953

Review 5.  Prenatal risk factors for internalizing and externalizing problems in childhood.

Authors:  Joyce Tien; Gary D Lewis; Jianghong Liu
Journal:  World J Pediatr       Date:  2019-10-15       Impact factor: 2.764

6.  Perception of risk regarding the use of medications and other exposures during pregnancy.

Authors:  Hedvig Nordeng; Eivind Ystrøm; Adrienne Einarson
Journal:  Eur J Clin Pharmacol       Date:  2009-10-20       Impact factor: 2.953

7.  Adherence with drug therapy in pregnancy.

Authors:  Doreen Matsui
Journal:  Obstet Gynecol Int       Date:  2011-12-26

8.  Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational Internet-based survey.

Authors:  Katri Hämeen-Anttila; Hedvig Nordeng; Esa Kokki; Johanna Jyrkkä; Angela Lupattelli; Kirsti Vainio; Hannes Enlund
Journal:  J Med Internet Res       Date:  2014-02-20       Impact factor: 5.428

9.  Assessment of adherence to medication during chronic illnesses in pregnancy.

Authors:  Smita Sontakke; Vrushali Takalikar; Jitendra Deshmukh; Vijay M Motghare; Mrunalini Kalikar; Avinash Turankar
Journal:  Perspect Clin Res       Date:  2020-05-07

Review 10.  Psychopharmacoteratophobia: Excessive fear of malformation associated with prescribing psychotropic drugs during pregnancy: An Indian perspective.

Authors:  Dushad Ram; Basavnna Gowdappa; H G Ashoka; Najla Eiman
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.